Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DETECTion of the Prevalence of Silent Atherosclerosis Across Adult Life and Development of a Risk Calculator to Predict Its Presence. Phase I of the REACT (Early Cure of Atherosclerosis) Project

NCT06692127 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT06692127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06692127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DETECTion of the Prevalence of Silent Atherosclerosis Across Adult Life and Development of a Risk Calculator to Predict Its Presence. Phase I of the REACT (Early Cure of Atherosclerosis) Project
Lead sponsor
Rigshospitalet, Denmark
Phase
Observational
Overall status
Active, not recruiting
Start date
November 27, 2024
Completion date
July 31, 2032
Enrollment
16,808 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, cardiovascular diseases, subclinical atherosclerosis